FHCCX (FHCCX) Stock Price & Analysis
FHCCX (FHCCX) rose 2.77% to USD 36.33 as of June 10, 2026 at 16:14 UTC, according to Nexqual real-time market data.
FHCCX last closed at USD 35.35; the session ranged USD 36.33–36.33 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 33.23–45.68 (NAS). Source: Nexqual, June 10, 2026 at 16:14 UTC.
Key Statistics (as of June 10, 2026 at 16:14 UTC)
| Price | USD 36.33 |
|---|---|
| Change | ▲ 2.77% (up) |
| Previous Close | USD 35.35 |
| Open | USD 36.33 |
| Day Range | USD 36.33 – 36.33 |
| 52-Week Range | USD 33.23 – 45.68 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (FHCCX)
Nexqual's technical model rates FHCCX "BUY" based on 5 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 16:14 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 57.62 (neutral) |
| vs SMA50 | Above (USD 35.25) |
| MACD | 0.16 (positive) |
Financial Health Score (FHCCX)
Nexqual rates FHCCX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 16:14 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FBTCX | Fidelity Advisor Biotechnology | USD 29.31 | ▲ 2.73% |
| FAFCX | Fidelity Advisor Series VII: Fi | USD 34.61 | ▲ 1.44% |
| FACGX | Fidelity Advisor Series II: Fid | USD 181.3 | ▼ 0.9% |
| FACDX | Fidelity Advisor Series VII: Fi | USD 55.57 | ▲ 2.77% |
| FNICX | Fidelity Advisor New Insights C | USD 33.9 | ▼ 0.12% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 16:14 UTC. This page is informational and not investment advice.